Health Care Select Sector SPDR Fund (XLV)

The Health Care Select Sector SPDR Fund (XLV) has garnered positive reviews from multiple experts, showcasing its ability to outperform the S&P 500 index significantly, with a notable 12% excess return over the past three months and a year-to-date return of 26.8%. It is perceived as a safe and steady investment choice, highlighted by its low beta of 0.51, which implies lower volatility compared to the broader market. The current market trend indicates a shift away from AI sectors, giving healthcare stocks a prime opportunity for growth. Experts suggest that there is potential for short-term alpha in the healthcare sector, influenced by ongoing developments in health treatments, such as GLP-1 medications. While predictions for 2026 suggest continued growth, the current year's substantial increase makes XLV an attractive prospect for investors seeking stability amidst market fluctuations.